Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Report by
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

ManukaGuard Allercleanse Nasal Spray - recalled due to Yeast Contamination, USA

February 10, 2021 10:00 PM

United States

Company name: NDAL MFG INC
Brand name: ManukaGuard
Product recalled: Allercleanse Nasal Spray
Reason of the recall: Due to Yeast Contamination
FDA Recall date: February 10, 2021
Recall details: NDAL MFG INC is voluntarily recalling one lot of Manukaguard Allercleanse, nasal spray to the consumer level. The Allercleanse nasal sprays have been found to be contaminated with yeast.

Risk Statement:  The use of Allercleanse (manuka honey) nasal spray contaminated with yeasts, in the population most likely to use it (children, adults, and elderly), may result in adverse events that necessitate medical or surgical intervention. However, use of this contaminated product in immunosuppressed individuals may result in life threatening invasive fungal infections.

NDAL MFG INC has not received any reports of adverse events related to this recall. The product is used as a NASAL SPRAY to clean nasal passages and sinuses of irritants and other environmental contaminants and is packaged in cardboard box with one nasal spray per box UPC 858631002128.  The affected Allercleanse lot is lot # 2010045 and BB 10/2023 expiration date.

Product was distributed Nationwide in the USA to 1 e-commerce website amazon.com, distributors and retail stores. NDAL MFG INC has notified its distributors and customers by e-mail followed by telephone and further email and has arranged for return/replacement etc. of all recalled products. 

Consumers/distributors/retailers that have product which is being recalled should stop using/return to place of purchase/discard/contact their doctor, etc., if they have not already done so. Consumers with questions regarding this recall can contact NDAL MFG INC by phone 1-800-916-1220 or e-mail address SUPPORT@MANUKAGUARD.COM, M-F 7:30 am to 4 pm PST.  Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.

Check the full recall details on fda.gov

Source: FDA

Reported By SafelyHQ.com User
More incidents from:
Recall
United States

Related Reports

November 29, 2020 9:25 PM

“The FSA announced the recall of raw dog food products by Happy Hounds Wales Ltd because they may contain salmonella.

FSA advises consumers not to use the recalled product. Instead, return it to the store from where it was bought for a full refund. When handling and serving raw pet food it is alw... See Moreays advised to clean utensils and feeding bowls thoroughly after use.

- Frozen Beef Kidney (1kg). Batch code: 962. Best before: 10/26/2021
- Frozen Whole Heart (Individual Item). Batch code: 962. Best before: 10/26/2021
- Frozen Chicken and Beef Sleeve (1kg). Batch code: 1344/962. Best before: 11/2/2021
- Frozen Lamb and Beef Sleeve (1kg). Batch code: 962-966. Best before: 11/4/2021
- Frozen Diced Heart (1.5kg). Batch code: 962. Best before: 10/26/2021

Check the full recall details on food.gov.uk

Source: FSA
See Less
Reported By SafelyHQ.com User

December 1, 2020 8:00 PM

“Company name: WishGarden Herbs
Brand name: WishGarden Herbal Remedies
Product recalled: Happy Ducts Compress
Reason of the recall: Product may be contaminated with Cronobacter sakazakii.
FDA Recall date: December 01, 2020
Recall details: WishGarden Herbs, Inc. is voluntarily recalling one lot o... See Moref Happy Ducts Compress to the consumer level. After becoming aware of a possible supply chain contamination, a retained product was found to contain the Cronobacter sakazakii bacteria. WishGarden has initiated this recall due to the possible bacterial contamination of Happy Ducts Compress products of lot 53664.

WishGarden Herbs has reported that no medical illnesses or harmful effects have resulted from the recalled products thus far. To date 36 of 46 units in distribution have been accounted for. Happy Ducts Compress, when contaminated with Cronobacter sakazakii and applied to breast tissue of nursing women, may result in serious and sometimes life-threatening infections of nursing infants. Infants can be exposed while nursing through residual bacteria on their mother’s skin.

Additionally, topical application of Happy Ducts Compress contaminated with Cronobacter sakazakii may cause soft tissue infections in nursing women when applied to broken skin such as cracked nipples. Catherine Hunziker, WishGarden President, stated “As a leading herbal product company for more than 40 years, we take the safety of our products seriously and we feel it is important to recall this product out of an abundance of caution. Consumer safety is our highest priority.”

Happy Ducts Compress is used by nursing women as an external compress applied to breast tissue. It is packaged in 3 oz containers and labelled with UPC 6-56490-20223-5. The affected Happy Ducts Compress affected lot is 53664, Exp 08/2022. The lot and expiration date can be found above the label barcode. This product was distributed through select practitioners and online retailers.

WishGarden Herbs is notifying its distributors and customers by phone and email. Consumers who have purchased this product through their practitioner or retail site should not open the package or should discontinue use immediately. Instead, they should dispose of the product or mail it directly to WishGarden Herbs corporate headquarters at 321 South Taylor Ave. Suite 100 Louisville, CO 80027 for a full refund.

Consumers with questions regarding this recall can contact WishGarden Herbs by calling the company’s recall hotline at 720-889-9878 (M-F, 9am - 5pm MST) or Email: recall@wishgardenherbs.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

December 9, 2020 5:00 PM

“Company name: Torrent Pharmaceuticals Limited
Brand name: Torrent Pharmaceuticals Limited
Product recalled: Anagrelide Capsule USP 1mg
Reason of the recall: Due to dissolution test failure
FDA Recall date: December 09, 2020
Recall details: Torrent Pharmaceuticals Limited is voluntarily recall... See Moreing one lot of Anagrelide Capsules, USP to the consumer level due to dissolution test failure detected during routine quality testing. Failed dissolution can result in a slower rate and extent of drug release leading to less anagrelide available in the body. For seriously ill patients with elevated platelet counts, less available anagrelide could increase the risk of clotting (blood coagulation) and clotting or bleeding events such as a heart attack or stroke which could be life-threatening.

To date, Torrent Pharmaceuticals Limited has not received any reports of adverse events related to this recall. Anagrelide is used to treat a blood cell disorder called thrombocythemia (also called thrombocytosis), which occurs when your body produces too many platelet cells. As the risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment, patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.  The product subjected to the recall is listed below and packaged in bottles. The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing the product.

- Anagrelide Capsule USP 1mg,100-count bottles. NDC: 13668-462-01. Lot/Batch: BFD1G001. Expiration Date: 12/2021

Anagrelide Capsules, USP were distributed nationwide to Torrent’s wholesale distributor and retail customers. Torrent Pharmaceuticals Limited is notifying its distributors and customers by phone and in writing to immediately discontinue distribution of the specific lots being recalled and to notify their sub-accounts. Torrent is arranging for return of all recalled products to Qualanex. Instructions for returning recalled products are given in the recall letter.

Consumers with medical questions regarding this recall or to report an adverse event can contact Torrent Pharmaceuticals Limited at 1-800-912-9561 (live calls received 8:00 am – 5:00 pm Eastern Time (Monday-Friday), voicemail available 8:00 am – 5:00 pm Eastern Time (Monday-Friday).

Consumers should also contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Any general questions regarding the return of this product should be directed to Qualanex at 1-888-424-4340 (live calls received 8 am - 5:00 pm Eastern Time, Monday-Friday).

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User
Covid-19 Vaccine Experience Notifications

December 28, 2020 8:00 PM

“Company name: Sunstar Americas, Inc.
Brand name: Paroex
Product recalled: Paroex Chlorhexidine Gluconate Oral Rinse, 4 oz and 16 oz
Reason of the recall: Potential contamination with Burkholderia lata
FDA Recall date: December 28, 2020
Recall details: Schaumburg, Illinois, Sunstar Americas, I... See Morenc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level. This product may be contaminated with the bacteria Burkholderia lata. This is an expansion of the recall initially announced on October 27, 2020. Use of the defective product in the immunocompetent host may result in oral and, potentially, systemic infections requiring antibacterial therapy. In the most at-risk populations, the use of the defective product may result in life-threatening infections, such as pneumonia and bacteremia.

To date, 29 adverse events have been reported to SAI related to this recall. Affected patients tested positive for Burkholderia lata infections, typically found in sputum cultures while under treatment for other serious medical conditions. Use of the contaminated product on patients with pre-existing respiratory conditions, including those infected with Covid-19, is particularly unsafe.

The prescription oral rinse product, available through healthcare professionals only, is indicated for use as part of a professional program for the treatment of gingivitis and is packaged as follows:

- 1789P GUM® Paroex® is distributed in cases each containing 6 amber bottles of 16 fluid ounce (473 ml) chlorhexidine rinse. The bottle has a childproof cap and a 15 ml metered dosage cup, is safety sealed, and is decorated with a multiple-panel wrap-around label.
- 1788P GUM® Paroex® is distributed in cases each containing 24 amber bottles of 4 fluid ounce (118.25 ml) chlorhexidine rinse. The bottle has a childproof cap, is safety sealed, and is decorated with a multiple-panel wrap-around label.

The product can be identified as shown in the images below Paroex was distributed Nationwide to Dental offices, Dental distributors, Pharmaceutical wholesalers, Dental schools, and Pharmacies. SAI is notifying its direct distributors and customers by USPS Priority mail and is arranging for return of all recalled products. Patients, pharmacies, and healthcare facilities in possession of these products should stop using and dispensing immediately.

Consumers with questions regarding this recall can contact SAI by phone at 1-800-528-8537 or email us.pcr@us.sunstar.com on Monday-Friday from 8am-5pm CST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product. Affected products and lot numbers follow below:

-Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% Size/ Form: 16 fl.oz. Amber Bottles. NDC #: 052376-021-02. Product Code: 1789P. Lots Recalled: ALL LOTS with expiration date from Dec. 31, 2020 through Sep. 30, 2022

- Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% Size/ Form: 4 fl.oz. Amber Bottles NDC #: 052376-021-04. Product Code: 1788P. Lots Recalled: ALL LOTS with expiration date from Dec. 31, 2020 through Sep. 30, 2022.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report Online Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178. Sunstar is committed to delivering safe, fully compliant products of the highest quality and is taking necessary steps to prevent future occurrence of this issue. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

January 8, 2021 6:01 PM

“Company name: Fresenius Kabi USA
Brand name: Fresenius Kabi
Product recalled: Ketorolac Tromethamine Injection, USP, 30 mg/mL
Reason of the recall: Presence of particulate matter
FDA Recall date: January 08, 2021
Recall details: Fresenius Kabi USA is voluntarily recalling a single lot of Ketoro... See Morelac Tromethamine Injection, USP, 30 mg/mL, 1 mL fill in a 2 mL amber vial to the user level due to the presence of particulate matter. Particulate matter was found in reserve sample vials. No adverse event reports have been received for the recalled lot, which was produced and sold in 2019.

Administration of products containing particulate matter could obstruct blood vessels and result in local irritation of blood vessels, swelling at the site of injection, a mass of tissue that could become inflamed and infected, blood clots traveling to the lung, scarring of the lung tissues, and allergic reactions that could lead to life-threatening consequences.

Ketorolac Tromethamine, a nonsteroidal anti-inflammatory drug, is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level. The total combined duration of use of oral Ketorolac Tromethamine and Ketorolac Tromethamine Injection should not exceed 5 days. Listed below is a table of the recalled lot distributed nationwide in the United States to wholesalers, distributors, hospitals, and pharmacies between March 28, 2019 and September 3, 2019.

Product Name/Product size: Ketorolac Tromethamine Injection, USP, 30mg / mL, 1 mL fill in a 2 mL amber vial
NDC Number: 63323-162-01
Product Code: 160201
Batch Number: 6121083
Expiration Date: 02/2021
First Ship Date: 03/28/2019
Last Ship Date: 09/03/2019

Fresenius Kabi is notifying its distributors and customers by letter and asking customers and distributors to check their stock immediately and to quarantine and discontinue the use and distribution of any affected product. Distributors should notify their customers and direct them to quarantine and discontinue distributing or dispensing the affected lot, and to return the product to Fresenius Kabi.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

January 17, 2021 11:59 PM

“The FSA announced the recall of several dog food products by Mars Petcare UK because they may contain high levels of vitamin D which exceed the maximum permitted intake.

FSA advises pet owners that if they have bought any of the following dog food products, you should stop feeding them to your do... See Moreg and contact Mars Petcare Customer Service at 0800 013 3131. If you have concerns that your pet may be showing symptoms of illness after eating one of the affected products, please contact a veterinarian.

- CHAPPIE Complete Chicken & Wholegrain Dry Dog Food (3kg). Batch code: 045F9MIN05. Best before: 44692
- PEDIGREE Mixer Adult Dry Dog Original (3kg). Batch code: 046E9MIN05 | 046F9MIN05 | 048A9MIN05. Best before: 12 February 2022 | 20 February 2022 | 22 February 2022
- PEDIGREE Mixer Adult Dry Dog Food Original (10kg). Batch code: 046E9MIN08 | 047C9MIN08. Best before: 12 February 2022 | 17 February 2022
- PEDIGREE Adult Complete Dry Dog Food with Chicken & Vegetables (12kg). Batch code: 046C9MIN08 | 046D9MIN08 | 046E9MIN08. Best before: 10 February 2022 | 11 February 2022 | 12 February 2022
- PEDIGREE Adult Complete Dry Dog Food with Chicken & Vegetables (2.6kg). Batch code: 045F9MIN05 | 047A9MIN05. Best before: 06 February 2022 | 15 February 2022

High levels of vitamin D fed to a pet over a short period (weeks/months) should not cause undue concern. Over a longer period of feeding, ingestion of elevated levels can lead to potential dog health issues. Vitamin D, when consumed at very high levels, can lead to serious health issues in dogs including renal dysfunction.

Check the full recall details on the FSA website food.gov.uk

Source: FSA
See Less
Reported By SafelyHQ.com User

January 27, 2021 9:01 PM

“Company name: Meitheal Pharmaceuticals, Inc.
Brand name: Meitheal Pharmaceuticals, Inc.
Product recalled: Cisatracurium Besylate Injection, USP 10mg per 5mL
Reason of the recall: Mislabeling
FDA Recall date: January 27, 2021
Recall details: Meitheal Pharmaceuticals, Inc. (“Meitheal”), annou... See Morenced today that it is voluntarily recalling one (1) lot of Cisatracurium Besylate Injection, USP 10mg per 5mL to the user level. The decision to recall the product was made after a product complaint revealed that a portion of Lot C11507A of cartons labeled as Cisatracurium Besylate Injection, USP 10mg per 5mL, containing 10-vials per carton, contained 10-vials mis-labeled as Phenylephrine Hydrochloride Injection, USP 100mg per 10mL. 

To date, Meitheal has not received reports of any adverse events or identifiable safety concerns attributed to the lot. There is a reasonable probability that a patient who requires cisatracurium for muscle paralysis as part of general anesthesia is administered phenylephrine instead would not receive any skeletal muscle relaxation and could cause a hyperadrenergic state resolution in elevated blood pressure, arrhythmia and cardiac/brain ischemia.  If this is not quickly diagnosed and treated, severe illness or death can occur. 

There is a reasonable probability that a patient who requires phenylephrine to increase their blood pressure, such as patients with severely low blood pressure, especially resulting from septic shock who is administered cisatracurium instead could result in a fast onset of muscle paralysis and decrease in oxygen. If this is not quickly diagnosed and treated, severe illness or death can occur within minutes. Cisatracurium Besylate Injection is used as a nondepolarizing neuromuscular blocker. 

The affected Cisatracurium Besylate Injection lot being recalled is C11507A, EXP. October 2021.  The product can be identified as a 5mL vial stoppered with a rubber stopper and sealed with aluminum seal having an Aqua color flip-off seal.  Meitheal commenced shipping the product to customers on August 19, 2020 which was distributed to wholesalers nationwide in the USA.

- Cisatracurium Besylate Injection, USP 10mg per 5mL. Lot Number: C11507A*. Expiration Date: October 2021*. NDC Number: 71288-712-06 (unit of sale) |71288-712-05 (unit of use). Distribution Dates: August 19, 2020 – January 04, 2021.

*Note: Mis-labeled product will have this same Lot Number of C11507A and Expiration Date of October 2021 but will be labeled on the vial as Phenylephrine Hydrochloride Injection, USP 100mg per 10mL, NDC 71288-808-77 (unit of use).

Meitheal has notified its distributors and customers in writing to arrange for return of all recalled product. Customers who have purchased the product should not open the carton or use its contents and should immediately quarantine and return the recalled lot of product. Customers who may have further distributed this product should promptly identify their customers and notify them at once of this product recall.

Consumers with questions regarding this recall can contact Meitheal’s Customer Service weekdays 8:00AM to 6:00PM CST at 844-824-8426. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax, as follows.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

February 16, 2021 11:55 PM

“The FSA announced the recall of Boots Multivitamins supplements by Boots because they have been incorrectly packed with multivitamins containing iron. This resulted in vitamin K not being present within the supplement and iron incorrectly added to the supplements instead. Iron has not been mentioned... See Moreon the label. This means the product is a possible health risk to individuals who may also be consuming iron supplements in addition to these multivitamins.

FSA advises consumers to stop taking the multivitamin supplements. Instead, return it to the Boots store from where it was bought for a full refund. This recall affects multivitamins sold between 12 and 19 January 2021 only.

- Boots Multivitamins (180 tablets). Item code: 80 57 311. Batch code: 1805 and 1806. Best before: end of November 2022.

This product does not contain vitamin K but does contain iron. Excess supplemental iron can result in gastrointestinal effects such as pain, discomfort, constipation or nausea and vomiting.

Check the full recall details on the FSA website food.gov.uk
See Less
Reported By SafelyHQ.com User

February 23, 2021 9:01 PM

“Company name: Medtronic
Brand name: Medtronic Valiant Navion™
Product recalled: Thoracic stent graft system
Reason of the recall: Due to endoleaks, stent fractures and stent ring enlargement
FDA Recall date: February 23, 2021
Recall details: Medtronic plc (NYSE:MDT), the global leader in medica... See Morel technology, has voluntarily issued a global recall of unused Medtronic Valiant Navion™ thoracic stent graft system and informed physicians to immediately cease use of the device until further notice. In accordance with its commitment to patient safety – and in consultation with independent physicians – Medtronic initiated this action in response to information recently obtained from the Valiant Evo Global Clinical Trial indicating that three patients in the Valiant Evo Global Clinical Trial were observed to have stent fractures, two of which have confirmed type IIIb endoleaks. One patient death was reported.

Following these observations, an independent imaging laboratory reviewed all available images from patients enrolled in the Valiant Evo Global Clinical Trial. Upon further analysis of the images, seven (7) out of 87 patients were observed to have stent ring enlargement beyond the design specification. Those observations require further assessment to determine potential clinical importance.

Medtronic is currently conducting a comprehensive technical root cause investigation, including further review of follow-up clinical trial imaging and commercial complaints and imaging. “There is nothing more important than the safety and well-being of patients,” said Nina Goodheart, senior vice president and president, Structural Heart & Aortic, which is reported as part of the Cardiac Vascular Group at Medtronic. “We treat matters of product safety with the highest priority and urgency. Our decision to implement this voluntary recall is necessary to ensure the utmost patient safety. As our investigation continues, we are committed to timely communication with physicians and regulatory bodies.”

Medtronic has contacted the U.S. Food and Drug Administration (FDA), along with other regulatory bodies around the world, to share information related to this issue. Medtronic will continue working directly with regulatory authorities on this global voluntary recall.

Patient Management Recommendations: Patients with a Medtronic Valiant Navion thoracic stent graft system should consult their physician with any questions. As part of the voluntary recall of unused product, physicians were sent written communication from Medtronic directing them to immediately cease use of the Medtronic Valiant Navion thoracic stent graft system and instructions for returning unused product to Medtronic. Medtronic advises physicians to retrospectively review all available images of patients treated with Valiant Navion thoracic stent graft system with specific attention to stent fractures and type IIIb endoleaks and contact Medtronic if any imaging findings are observed.

Medtronic urges physicians to follow best clinical practices and evaluate patients with at least annual follow-up according to the imaging recommendations in the Medtronic Valiant Navion thoracic stent graft system Instructions for Use (IFU). As always, physicians are asked to notify Medtronic of any adverse events or product safety issues associated with use of any Medtronic product, which also should be reported to the FDA's MedWatch Adverse Event Reporting program. Outside of the U.S. adverse events or product safety issues associated with use of any Medtronic product should be reported to the appropriate competent authority.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

2nd. Pfizer COVID injection., Hesperia, CA, USA

Symptoms: Fever Headache Chills Fatigue Body Ache
Hesperia, CA, USA

March 3, 2021 7:04 PM

“I was given my second Pfizer vaccine 3/1/2021. The injection itself didnt hurt, however, that night I started not feeling well, I had the chills, kept waking up through the night, had a headache, a fever, my body ached, was tired and the injection site was tender. Still glad I got it, I just took it... See Moreeasy and slept throughout the day. See Less
Reported By SafelyHQ.com User

Recent Interesting Reports

February 15, 2021 1:00 AM

“I ordered 2 chainsaws from an ad on the internet which popped up while playing cards on my phone from a web company called Blackcass.com. I thought that I was ordering rechargable woodcutter/chainsaws, but received two chains instead. They would not refund my money or allow me to return and get a re... See Morefund. They said that I had ordered the chains when I only see a big picture of a chainsaw. Their website is misleading to say the least. I would say I was scammed. They also scam people on their website with another chainsaw they are selling that has the well known brand name of Stihl on the saw. Then they send you an off brand saw made in China. Fraud indeed! See Less
Reported By SafelyHQ.com User

February 11, 2021 5:22 PM

“Got my second Moderna Covid-19 vaccine shot, no side effects this time. A little tired and thirsty but so far so good. See Less
Reported By SafelyHQ.com User

Covid 19 vaccine symptoms, Indianapolis, IN, USA

Symptoms: Nausea Headache Fatigue Skin Rash Soreness
Indianapolis, IN, USA

February 2, 2021 10:30 PM

“I am a female, 26 years old.An RN at Riley Children’s hospital. I received the moderne vaccine. The first dose, the physical shot was less painful than flu vaccine. Only symptom was sore arm for 2 days. Second dose, much worse. Woke up 24 hrs later feeling fatigued, nauseous, headache, and developed... See Morelarge red circular rash around injection site. Lasted 24 hours. Was hot to touch and very painful. No fevers. Better the next day. See Less
Reported By SafelyHQ.com User
Covid-19 Vaccine Experience Notifications

February 7, 2021 11:58 PM

“The FDA observed the website offers “Corona Destroyer Tea” for sale in the United States in two options, “Prevention” and “Reversal,” and that this product is intended to mitigate, prevent, treat, diagnose, or cure COVID-19[1] in people.

Based on FDA review, this product is an unapproved new dr... See Moreug sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, this product is a misbranded drug under section 502 of the FD&C Act, 21 U.S.C. § 352. The introduction or delivery for introduction of this product into interstate commerce is prohibited under sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and d. Some claims on the website and product label establish the intended use of the product and misleadingly represent it as safe and/or effective for the treatment or prevention of COVID-19

For more information click here: fda.gov
See Less
Reported By SafelyHQ.com User

Casher I’s feeling low fever, Santa Clara, CA, USA

Symptoms: Fever
Santa Clara, CA, USA

February 15, 2021 4:47 PM

“The cashier is felling sick. Every one got flu in this restaurant. This place infected with COVID 19
I got full sick. All employees are sick and needed fully attention See Less
Reported By SafelyHQ.com User

February 28, 2021 7:22 AM

“Ordered a mini chainsaw from Wayfale! What I got is a necklace! Am Stink Sour 😡!! I just have a little widow's pension, and for me it's a lot of money. The advertisement is so misleading!!! See Less
Reported By SafelyHQ.com User

February 17, 2021 6:09 PM

“A scam regarding a small knock-off chain saw that is the center of a scam by Blackcass of Houston, TX or LA, CA or probably China somewhere. We ordered a Blackcass 2020 Hot selling GTA 26 Battery-Powered Wood Cutter X 1 in December 2020. We did received, via USPS, a 25" long segment of chain saw l... See Moreinks with Orange handles on each end, so it is NOT Battery-Operated. One of the photos in the Blackcass ad that are associated with this SCAM are EXACTLY the same photo used by the very legitimate Stihl company model GTA-26...only the word, "Stihl" is omitted on the Blackcass ad's photo. So, consumers and the real manufacturer are BOTH being scammed. See Less
Reported By SafelyHQ.com User

Door frames, bed frame, cabinets and air vents, Philadelphia, PA, USA

Symptoms: Other Dehydration Headache Muscle Pain
Philadelphia, PA, USA

February 2, 2021 9:31 PM

“I am sick., My apartment has a rusting metal. Continuous everyday. I have reported to Cyber Village management and staff that there is a substance causing the metal to rust in my apartment. It is a colorless and odorless substance that rusts metal. This poisonous substance is in my food, clothes,... See Morehair shampoos and conditioners, hand and body lotions and all over my apartment. This poisonous substance is making me sick. This substance causes a dehydration. Also, this poison causes metal to RUST. The evidence of this Rust is on the following: Bathroom door frame and all metal objects in the bathroom are RUSTED Recliner is RUSTED Bedframe is RUSTED Air Vents rusted It is colorless and odorless; however, the effects are server chest congestion, cough, eye and throat irritation. It dries the air which dries my body and my nasal area. It causes server headache and chest/head congestion. It also causes muscle pain and darkens my skin. Also, I have the feelings of pins and needles on hands and feet when it is present on my furniture. I belive someone is poisoning me. This is dangerous for me as well as the community. If this is done to me, it can happen to anyone. See Less
Reported By SafelyHQ.com User

February 3, 2021 1:00 PM

“Company name: Apotex Corp
Brand name: Apotex Corp.
Product recalled: Enoxaparin Sodium Injection, USP
Reason of the recall: Packaging error resulting in incorrect dosage listed
FDA Recall date: February 03, 2021
Recall details: Apotex Corp is voluntarily recalling two (2) batches of Enoxaparin... See MoreSodium Injection, USP to consumer level due to a packaging error resulting in some syringes barrels containing 150 mg/mL markings (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL strength) on the syringe barrel and vice versa. The packaging error was discovered during a customer complaint investigation. To date, Apotex has not received any reports of adverse events related to use of these two batches. The affected product is manufactured by Gland Pharma Limited, Hyderabad, India.

Health Hazard Assessment: Incorrect syringe barrel marking could lead to miscalculation and inaccurate dose administration to patients. In one recalled batch (batch CS008, strength 100 mg/mL), if a consumer used a 150 mg/mL concentration packaged in a barrel corresponding to a l00 mg/mL concentration, patients could receive 3.75 mg of Enoxaparin, instead of 3 mg of Enoxaparin. In another recalled batch (batch CT003, strength 120 mg/0.8mL), if a consumer used a 100 mg/mL concentration packaged in a barrel corresponding to a 150 mg/mL concentration, patients would receive 2 mg of Enoxaparin rather than 2.5 mg of Enoxaparin. Accidental overdosage following administration of enoxaparin sodium injection may lead to bleeding complications. Alternative, if the dose administered is less than prescribed, the patient may be subject to developing some blood clotting conditions.

Enoxaparin Sodium injection is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), Treatment of Acute Deep Vein Thrombosis, prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, when concurrently administered with aspirin and Treatment of Acute ST-Segment Elevation Myocardial Infarction.

The affected Enoxaparin Sodium Injection, USP can be identified by NDC numbers stated on carton and label of the product.

Product: Enoxaparin Sodium Injection, USP
Batch #: CS008
Strength: 100 mg/mL
Syringe Barrel Measurement Markings: 100 mg/mL
Pack Size: 10 x 1mL Single Dose Syringes
NDC NumberOn Carton: 60505-0795-4
NDC Number On label: 60505-0795-1
UPC Code on Carton: 360505079544
UPC Code on label: (01)10360505079510

Product: Enoxaparin Sodium Injection, USP
Batch # : CT003
Strength: 120 mg/0.8mL
Syringe Barrel Measurement Markings: 150 mg/ mL
Pack Size: 10 x 0.8 mL Single Dose Syringes
NDC NumberOn Carton: 60505-0796-4
NDC Number On label: 60505-0796-0
UPC Code on Carton: 360505079643
UPC Code on label: (01)10360505079602

The two (2) affected batches of Enoxaparin Sodium Injection, USP were distributed by Apotex nationwide in the USA to Wholesalers and Warehousing Chains. Apotex Corp. is currently notifying its affected direct account Wholesalers and Warehousing Chains, via mail (FedEx Standard Overnight) by mailing a recall notification letter and is arranging for return of all recalled product.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

February 28, 2021 4:02 PM

“Order was sent but just a chain. This is misleading to alot of people who they are ripping off. See Less
Reported By SafelyHQ.com User